Attention-deficit/hyperactivity disorder.
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder that affects 4-8% of the population in children, adolescents and adults. Aspects of ADHD can persist from childhood and adolescence into adulthood in 50% to 70% of persons with this DSM-5 disorder. Co-morbidities are co...
| Publicado en: | International Journal of Child Health & Human Development Vol. 15; no. 4; pp. 299 - 343 |
|---|---|
| Autores principales: | , |
| Formato: | review Journal Article |
| Publicado: |
Nova Science Publishers, Inc.
2022
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=163211787&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 163211787 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 19395965 903J jtl: International Journal of Child Health & Human Development issn: 19395965 maglogo: N pubinfo: dt: 2022 vid: 15 iid: 4 pid: 1040 pub: Nova Science Publishers, Inc. place: Hauppauge, New York artinfo: ui: 163211787 163211787 163211787 163211787 ppf: 299 ppct: 44 formats: fmt: @attributes: type: P tig: atl: Attention-deficit/hyperactivity disorder. aug: au: Greydanus, Donald E. Patel, Dilip R. affil: Department of Pediatric and Adolescent Medicine, Western Michigan University Homer Stryker MD School of Medicine, Kalamazoo, Michigan, USA sug: subj: Attention Deficit Hyperactivity Disorder Attention Deficit Hyperactivity Disorder Diagnosis Attention Deficit Hyperactivity Disorder Epidemiology Attention Deficit Hyperactivity Disorder Symptoms Attention Deficit Hyperactivity Disorder Etiology Diagnosis, Differential Comorbidity Attention Deficit Hyperactivity Disorder Therapy Child, Preschool Child Adolescence DSM Behavior Therapy Psychopharmacology Patient Education Social Skills Training Biofeedback Parents Education Occupational Therapy Physical Therapy Central Nervous System Stimulants Therapeutic Use Adrenergic alpha-Antagonists Therapeutic Use Serotonin Uptake Inhibitors Therapeutic Use Child, Preschool: 2-5 years Child: 6-12 years Adolescent: 13-18 years ab: Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder that affects 4-8% of the population in children, adolescents and adults. Aspects of ADHD can persist from childhood and adolescence into adulthood in 50% to 70% of persons with this DSM-5 disorder. Co-morbidities are common in persons with ADHD and must be considered in the overall therapy plan. Management considerations include behavioral-psychology therapy typically along with psychopharmacology. Nonpharmacological approaches to ADHD include placement in appropriate educational classes, social skills training, biofeedback, parental training, occupational training, physical therapy, and psychological therapy as needed in an individualized approach. Psychopharmacology can include psychostimulants, alpha-2 agonists, a norepinephrine reuptake inhibitor, and others. Careful, long-term management is important for pediatric persons with ADHD and co-morbid conditions that may be present. pubtype: Academic Journal doctype: review Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|